Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.625 EUR | +6.62% | -10.85% | -5.74% |
Sales 2024 * | 64.79M 69.91M | Sales 2025 * | 75.94M 81.95M | Capitalization | 74.28M 80.16M |
---|---|---|---|---|---|
Net income 2024 * | -5M -5.4M | Net income 2025 * | -2M -2.16M | EV / Sales 2024 * | 1.52 x |
Net Debt 2024 * | 24.4M 26.33M | Net Debt 2025 * | 22.75M 24.55M | EV / Sales 2025 * | 1.28 x |
P/E ratio 2024 * |
-20.4
x | P/E ratio 2025 * |
-25
x | Employees | 311 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.38% |
Latest transcript on BRAIN Biotech AG
1 day | +5.00% | ||
1 week | -9.82% | ||
Current month | -10.74% | ||
1 month | -12.75% | ||
3 months | -7.18% | ||
6 months | -17.88% | ||
Current year | -4.64% |
Managers | Title | Age | Since |
---|---|---|---|
Adriaan Moelker
CEO | Chief Executive Officer | 60 | 20-01-31 |
Director of Finance/CFO | 54 | 20-04-30 | |
Alexander Pelzer
CTO | Chief Tech/Sci/R&D Officer | 38 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Majerus
CHM | Chairman | 63 | 19-03-06 |
Stephen Catling
BRD | Director/Board Member | 59 | 20-10-13 |
Director/Board Member | 70 | 20-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 3.45 | +1.47% | 2 906 |
24-03-27 | 3.4 | -1.45% | 7,055 |
24-03-26 | 3.45 | -6.25% | 10,988 |
24-03-25 | 3.68 | -3.66% | 5,803 |
24-03-22 | 3.82 | -1.29% | 8,011 |
Delayed Quote Xetra, March 28, 2024 at 06:44 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.64% | 80.37M | |
-40.99% | 170M | |
-3.78% | 53.5M |